行情

PTN

PTN

Palatin科技
AMEX

实时行情|Nasdaq Last Sale

0.3645
+0.0145
+4.14%
盘后: 0.3500 -0.0145 -3.98% 19:58 05/27 EDT
开盘
0.3680
昨收
0.3500
最高
0.3681
最低
0.3560
成交量
15.38万
成交额
0
52周最高
0.9600
52周最低
0.3150
市值
8,448.15万
市盈率(TTM)
-2.3202
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解PTN最新的财务预测,通过PTN每股收益,每股净资产,每股现金流等数据分析Palatin科技近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

66.67%强力推荐
33.33%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测PTN价格均价为3.333,最高价位5.00,最低价为2.000。
最高5.00
均价3.333
最低2.000
现价0.3645
EPS
实际EPS
预期EPS
-0.05-0.04-0.02-0.01
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
机构持股
总机构数: 98
机构持股: 4,469.12万
持股比例: 19.28%
总股本: 2.32亿
类型机构数股数
增持
32
480.92万
建仓
20
135.83万
减持
17
134.26万
平仓
6
112.48万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+3.72%
制药与医学研究
+1.28%
高管信息
Non-Executive Chairman/Independent Director
John Prendergast
President/Chief Executive Officer/Director
Carl Spana
Chief Financial Officer/Chief Operating Officer/Executive Vice President/Treasurer/Secretary
Stephen Wills
Independent Director
Robert deVeer
Independent Director
Alan Dunton
Independent Director
Joseph Hull
Independent Director
Anthony Manning
Independent Director
Arlene Morris
暂无数据
暂无数据
PTN 简况
Palatin Technologies, Inc. (Palatin), is a biopharmaceutical company. Palatin is focused on developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Palatin product candidates are targeted receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. The melanocortin receptor (MCr) system has effects on food intake, metabolism, sexual function, inflammation, and immune system responses. The natriuretic peptide receptor (NPR) system regulates cardiovascular functions and tissue homeostasis, and therapeutic agents modulating this system have potential to treat cardiovascular and fibrotic diseases. Palatin lead product includes Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Its other product line includes PL9643 for dry eye disease and anti-inflammatory ocular indications and Oral PL8177 for inflammatory bowel diseases.

微牛提供Palatin Technologies, Inc.(AMEX-PTN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的PTN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易PTN股票基本功能。